A 23-Gene Prognostic Index Predicts Progression and Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer

Seon-Kyu Kim; Young Joon Byun; Seong-Hwan Park; Xuan-Mei Piao; Chuang-Ming Zheng; Seongmin Moon; Kyeong Kim; Sun Jin Song; Ho Won Kang; Won Tae Kim; Ok-Jun Lee; Yung Hyun Choi; Sung-Kwon Moon; Wun-Jae Kim; Young Deuk Choi; Seon-Young Kim; Seok Joong Yun

doi:10.1016/j.eururo.2024.01.001

A 23-Gene Prognostic Index Predicts Progression and Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer

Eur Urol. 2024 Apr;85(4):400-402. doi: 10.1016/j.eururo.2024.01.001. Epub 2024 Jan 11.

Authors

Seon-Kyu Kim¹, Young Joon Byun², Seong-Hwan Park³, Xuan-Mei Piao², Chuang-Ming Zheng², Seongmin Moon⁴, Kyeong Kim⁵, Sun Jin Song⁶, Ho Won Kang⁷, Won Tae Kim⁷, Ok-Jun Lee⁸, Yung Hyun Choi⁹, Sung-Kwon Moon¹⁰, Wun-Jae Kim¹¹, Young Deuk Choi¹², Seon-Young Kim¹³, Seok Joong Yun¹⁴

Affiliations

¹ Aging Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea; Department of Bioscience, University of Science and Technology, Daejeon, Republic of Korea; Personalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
² Department of Urology, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.
³ Aging Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea; Department of Bioscience, University of Science and Technology, Daejeon, Republic of Korea.
⁴ Department of Urology, Chungbuk National University Hospital, Cheongju, Republic of Korea; Department of Integrated Medical Science, College of Medicine, Chungbuk National University, Cheongju, Republic of Korea.
⁵ Department of Urology, Chungbuk National University Hospital, Cheongju, Republic of Korea.
⁶ Department of Integrated Medical Science, College of Medicine, Chungbuk National University, Cheongju, Republic of Korea; Department of Emergency, Chungbuk National University Hospital, Cheongju, Republic of Korea.
⁷ Department of Urology, Chungbuk National University College of Medicine, Cheongju, Republic of Korea; Department of Urology, Chungbuk National University Hospital, Cheongju, Republic of Korea.
⁸ Department of Pathology, Chungbuk National University College of Medicine, Cheongju, Republic of Korea; Department of Pathology, Chungbuk National University Hospital, Cheongju, Republic of Korea.
⁹ Department of Biochemistry, Dong-eui University College of Korean Medicine, Busan, Republic of Korea.
¹⁰ Department of Food and Nutrition, Chung-Ang University, Ansung, Republic of Korea.
¹¹ Institute of Urotech, Cheongju, Republic of Korea.
¹² Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
¹³ Korea Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
¹⁴ Department of Urology, Chungbuk National University College of Medicine, Cheongju, Republic of Korea; Department of Urology, Chungbuk National University Hospital, Cheongju, Republic of Korea. Electronic address: sjyun@chungbuk.ac.kr.

PMID: 38216401
DOI: 10.1016/j.eururo.2024.01.001

No abstract available

Publication types

Letter

MeSH terms

Adjuvants, Immunologic / therapeutic use
Administration, Intravesical
BCG Vaccine / therapeutic use
Disease Progression
Humans
Neoplasm Invasiveness
Neoplasm Recurrence, Local
Non-Muscle Invasive Bladder Neoplasms*
Prognosis
Urinary Bladder Neoplasms* / drug therapy
Urinary Bladder Neoplasms* / genetics

Substances

BCG Vaccine
Adjuvants, Immunologic